American Society of Anesthesiologists Task Force on Perioperative Blood Management. Practice guidelines for perioperative blood management: an updated report by the American Society of Anesthesiologists Task Force on Perioperative Blood Management. Anesthesiology. 2015;122(2):241–275.

Carson JL, Stanworth SJ, Guyatt G, et al.Red Blood Cell Transfusion: 2023 AABB International Guidelines. JAMA. 2023;330(19):1892–1902.

Carson JL, Stanworth SJ, Roubinian N, et al.Transfusion thresholds and other strategies for guiding allogeneic red blood cell transfusion. Cochrane Database Syst Rev. 2016;10(10):CD002042.

Cotton BA, Dossett LA, Haut ER, et al.Multicenter validation of a simplified score to predict massive transfusion in trauma. J Trauma. 2010;69(1):S33–S39.

Crash-2 Trial Collaborators. Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial. Lancet. 2010;376(9734):23–32.

Fergusson DA, Hebert PC, Mazer CD, et al.A comparison of aprotinin and lysine analogues in high-risk cardiac surgery. N Engl J Med. 2008;358(22):2319–2331.

Goodnough LT. Risks of blood transfusion. Crit Care Med. 2003;31(12):S678–S686.

Goodnough LT, Brecher ME, Kanter MH, AuBuchon JP. Transfusion medicine. I. Blood transfusion. N Engl J Med. 1999;340(6):438–447.

Goodnough LT, Brecher ME, Kanter MH, AuBuchon JP. Transfusion medicine: II. Blood conservation. N Engl J Med. 1999;340(7):525–533.

Hebert PC, Wells G, Blajchman MA, et al.A multicenter, randomized controlled clinical trial of transfusion requirements in critical care. N Engl J Med. 1999;340(6):409–417.

Holcomb JB, Tilley BC, Baraniuk S, et al.Transfusion of plasma, platelets, and red blood cells in a 1:1:1 vs a 1:1:2 ratio and mortality in patients with severe trauma: the PROPPR randomized clinical trial. J Am Med Assoc. 2015;313(5):471–482.

Kopko PM, Holland PV. Transfusion-related acute lung injury. Br J Haematol. 1999;105(2):322–329.

Lake CL, Moore RA, eds. Blood: Hemostasis, Transfusion, and Alternatives in the Perioperative Period. Raven Press; 1995.

Mistry N, Hare GMT, Shehata N, et al.Transfusion thresholds for acute coronary syndromes-insights from the TRICS-III randomized controlled trial, systematic review, and meta-analysis. J Am Heart Assoc. 2023;12(1):e028497.

O’Connell NM, Perry DJ, Hodgson AJ, et al.Recombinant FVIIa in the management of uncontrolled hemorrhage. Transfusion. 2003;43(12):1711–1716.

Rao SV, Jollis JG, Harrington RA, et al.Relationship of blood transfusion and clinical outcomes in patients with acute coronary syndromes. J Am Med Assoc. 2004;292(13):1555–1562.

Raphael J, Mazer CD, Subramani S, et al.Society of cardiovascular anesthesiologists clinical practice improvement advisory for management of perioperative bleeding and hemostasis in cardiac surgery patients. Anesth Analg. 2019;129(5):1209–1221.

Shaw AD, Stafford-Smith M, White WD, et al.The effect of aprotinin on outcome after coronary-artery bypass grafting. N Engl J Med. 2008;358(8):784–793.

Tanaka KA, Bader SO, Görlinger K. Novel approaches in management of perioperative coagulopathy. Curr Opin Anaesthesiol. 2014;27(1):72–80.

Tibi P, McClure RS, Huang J, et al.STS/SCA/AmSECT/SABM update to the clinical practice guidelines on patient blood management. Ann Thorac Surg. 2021;112(3):981–1004.

WOMAN Trial Collaborators. Effect of early tranexamic acid administration on mortality, hysterectomy, and other morbidities in women with post-partum haemorrhage (WOMAN): an international, randomised, double-blind, placebo-controlled trial. Lancet. 2017;389(10084):2105–2116.